Be part of the research that changes care. M.I.A.L. Healthcare gives patients access to international clinical trials, led by a leading medical and scientific team. Enrolling in a trial means contributing directly to the advancement of medicine, with your care pathway supported every step of the way.
Clinical expertise in the service of research
Dr Teresa Castiello is National Coordinating Investigator (NCI) and Principal Investigator (PI) on numerous international clinical trials, with established expertise in running studies in cardiovascular and neurological disease.
M.I.A.L. Healthcare invites patients to help drive scientific research forward by enrolling in our clinical trials: every participation is a concrete step towards more effective, safer and more accessible treatments for everyone, today and in the future.
Our collaborations
M.I.A.L. Healthcare's clinical research is developed together with leading scientific and industry partners, ensuring patients benefit from the highest standards of quality, safety and innovation.
Dementech Neurosciences ↗
A private neurology and psychiatry clinic based in London, involved in international clinical trials for neurodegenerative conditions. Our collaboration with Dementech strengthens the diagnostic and research pathway in neurology.
Heartfelt Technology ↗
A technology partner specialising in solutions for the monitoring and management of heart failure (HF), supporting more accurate clinical trials and consistent patient follow-up.
Eli Lilly ↗
An international pharmaceutical company, with over 150 years dedicated to research in cardiovascular, neurological, oncological and metabolic disease. Our collaboration with Lilly allows M.I.A.L. to offer patients access to cutting-edge experimental treatments.
Our currently active clinical trials
If you are living with one of the following conditions, you may be eligible to take part in one of our clinical studies.
Cardiology
Pericarditis
Clinical studies for patients with acute, recurrent or chronic pericarditis, evaluating new therapies aimed at reducing inflammation, preventing recurrence and improving long-term quality of life.
Lipid Metabolism
Familial Hypercholesterolaemia (FH)
Research programmes for patients with familial hypercholesterolaemia, studying innovative therapies designed to lower LDL cholesterol and the cardiovascular risk associated with this inherited condition.
Cardiology
Heart Failure (HF)
Trials for patients with heart failure, evaluating new therapeutic approaches and monitoring technologies, with the aim of improving symptom management and day-to-day quality of life.
These are just some of the studies currently under way. New clinical trials in other therapeutic areas are being set up: get in touch to find out whether a suitable study is available for your condition.
Would you like to know more?
Our team is on hand to assess your eligibility, answer any questions and support you throughout every stage of the process, with the utmost care and transparency.
Contact us about enrolment: info@mial.healthcare
Participation in a clinical trial is always voluntary and subject to the eligibility criteria of the specific study, as assessed by the medical team. Every trial is conducted in accordance with Good Clinical Practice (GCP) standards and under the oversight of the relevant ethics committees.